Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil fMRI Study in OSAHS
NCT00711516Phase 4Completed
- Sponsor
- Cephalon, Inc.
- Start
- Sep 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of armodafinil in Hypersomnia (HS), sponsored by Cephalon, Inc.. Started Sep 2008; status: completed.
02
Drugs
armodafinil
03
Conditions
Hypersomnia (HS)
Beyond the preview
Go deeper on NCT00711516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711516.